文献速递重症综合管理与镇静镇痛

重症监护后远程医疗照护模式的随机对照试验(WFIT)

A Randomized Controlled Trial of a Post-ICU Telehealth Care Model (WFIT).
PubMed 文献 · Am J Respir Crit Care Med · 2025-01-01
一句话结论单中心RCT显示,ICU后远程医疗干预与增强对照相比无明确增量净获益,总医疗支出均值干预组8086.50美元 vs 对照组7801.10美元,增量净获益1958.29美元(95%CI -5779.56至9696.14)。

该单中心随机对照试验纳入400例脓毒症和/或急性呼吸衰竭ICU患者,既往一年住院≤2次,且非从收容所、专业护理机构或长期急性护理医院转入或转出。干预组在ICU出院后1周和2周接受计划远程医疗访视,并在6个月内按需访视,由接受过ICU后康复培训的临床医生提供。主要结局为干预的成本效果。结果显示,急诊就诊和住院的总医疗支出均值(标准差)在增强对照组为7801.10美元(15461.03),干预组为8086.50美元(17464.87),增量净获益为1958.29美元(95%CI -5779.56至9696.14)。两组在本医疗系统内的急诊就诊相同,但患者报告的外院急诊就诊不同(增强对照组每100患者每月0.97次 vs 干预组2.43次;P=0.03)。再入院、死亡率、生活质量评分和总体患者满意度评分两组相似。结论认为该干预与标准照护相比无明确增量净获益。

要点

  • 单中心RCT纳入400例脓毒症和/或急性呼吸衰竭ICU患者,干预组在ICU出院后1周和2周接受计划远程医疗访视,6个月内按需访视。
  • 急诊和住院总医疗支出均值:增强对照组7801.10美元(SD 15461.03) vs 干预组8086.50美元(SD 17464.87),增量净获益1958.29美元(95%CI -5779.56至9696.14)。
  • 本医疗系统内急诊就诊两组相同,但患者报告的外院急诊就诊干预组更高(每100患者每月2.43次 vs 0.97次;P=0.03)。
  • 再入院、死亡率、生活质量评分和总体患者满意度评分两组相似。
  • 结论:与标准照护相比,ICU后远程医疗干预未显示明确增量净获益。

适用人群与场景

  • 纳入:ICU患者,患有脓毒症和/或急性呼吸衰竭,既往一年住院≤2次,且非从收容所、专业护理机构或长期急性护理医院转入或转出。
  • 排除:从收容所、专业护理机构或长期急性护理医院转入或转出者;既往一年住院超过2次者。

处置流程与药物剂量

  • 干预组:ICU出院后1周和2周接受计划远程医疗访视,并在6个月内按需访视,由接受过ICU后康复培训的临床医生提供。
  • 对照组:增强对照(attention control)。

研究设计与关键结果

  • 研究类型:单中心随机对照试验,样本量400例ICU患者(脓毒症和/或急性呼吸衰竭)。
  • 主要结局(成本效果):急诊和住院总医疗支出均值(SD)增强对照组7801.10美元(15461.03) vs 干预组8086.50美元(17464.87);增量净获益1958.29美元(95%CI -5779.56至9696.14)。
  • 次要结局:本医疗系统内急诊就诊两组相同;患者报告的外院急诊就诊增强对照组每100患者每月0.97次 vs 干预组2.43次(P=0.03)。
  • 再入院、死亡率、生活质量评分和总体患者满意度评分两组相似。

证据类型、等级与局限

  • 证据类型:单中心随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该RCT显示ICU后远程医疗干预与增强对照相比无明确增量净获益,再入院、死亡率、生活质量和满意度相似。
  • 干预组患者报告的外院急诊就诊更高(每100患者每月2.43次 vs 0.97次;P=0.03),而本医疗系统内急诊就诊两组相同。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Rationale: Survivors of critical illness are at high risk for poor long-term outcomes, including readmissions, reduced quality of life, and mortality. A post-ICU telehealth care model may improve outcomes. Objectives: We sought to evaluate the cost-effectiveness and clinical efficacy of a post-ICU telehealth care model. Methods: We performed a single-center randomized controlled trial of 400 ICU patients with sepsis and/or acute respiratory failure, who had two or fewer hospital admissions in the past year, and who were not admitted from or discharged to hospice, a skilled nursing facility, or a long-term acute care hospital. The intervention group had scheduled telehealth visits at 1 and 2 weeks after ICU discharge and as needed for 6 months with a clinician trained in post-ICU recovery. The primary outcome is the cost-effectiveness of the intervention. Measurements and Main Results: Overall healthcare spending on emergency room (ER) visits and hospitalizations were a mean (SD, in U.S. dollars) $7,801.10 ($15,461.03) in the attention control group versus $8,086.50 ($17,464.87) in the intervention group, with a calculated incremental net benefit of $1,958.29 (-$5,779.56 to $9,696.14). ER visits to our healthcare system were the same between groups, but patient-reported ER visits to outside hospitals were different (0.97 per 100 patients per month in the attention control group vs. 2.43 in the intervention group; P = 0.03). Readmissions, mortality, quality-of-life scores, and overall patient satisfaction scores were similar between groups. Conclusions: This randomized controlled trial of a post-ICU telehealth intervention demonstrated wide variation but no clear incremental net benefit compared with standard care. Clinical trial registered with www.clinicaltrials.gov (NCT04576065).

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Bakhru RN, Flores L, Cain JM, et al. A Randomized Controlled Trial of a Post-ICU Telehealth Care Model (WFIT). Am J Respir Crit Care Med. 2025. PMID: 40532205. doi:10.1164/rccm.202411-2167OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。